Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If You Use a Screen Reader

This content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.

Infection of Cells by Varicella Zoster Virus: Inhibition of Viral Entry by Mannose 6-Phosphate and Heparin

Zhenglun Zhu, Michael D. Gershon, Richard Ambron, Christopher Gabel and Anne A. Gershon
Proceedings of the National Academy of Sciences of the United States of America
Vol. 92, No. 8 (Apr. 11, 1995), pp. 3546-3550
Stable URL: http://www.jstor.org/stable/2367104
Page Count: 5
  • Read Online (Free)
  • Subscribe ($19.50)
  • Cite this Item
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Infection of Cells by Varicella Zoster Virus: Inhibition of Viral Entry by Mannose 6-Phosphate and Heparin
Preview not available

Abstract

Envelope glycoproteins of varicella zoster virus (VZV) contain mannose 6-phosphate (Man6P) residues. We now report that Man6P competitively and selectively inhibits infection of cells in vitro by cell-free VZV; furthermore, dephosphorylation of VZV by exposure to alkaline phosphatase rapidly destroys infectivity. Cells are also protected from VZV in a concentration-dependent manner by heparin (ED50 = 0.23 μg/ml; 95% confidence limits = 0.16-0.26 μ/ml) but not by chondroitin sulfate. Both heparin and Man6P are protective only when present about the time of inoculation. Heparin but not Man6P interferes with the attachment of VZV to cell surfaces; moreover, VZV binds to heparin-affinity columns. These data are compatible with a working hypothesis, whereby VZV attaches to cell surfaces by binding to a heparan sulfate proteoglycan. This binding stabilizes VZV, making possible a low-affinity interaction with another Man6P-dependent receptor, which is necessary for viral entry.

Page Thumbnails

  • Thumbnail: Page 
3546
    3546
  • Thumbnail: Page 
3547
    3547
  • Thumbnail: Page 
3548
    3548
  • Thumbnail: Page 
3549
    3549
  • Thumbnail: Page 
3550
    3550